Khanna, S., Atalay, M., Laaksonen, D
The peptide primarily activates melanocortin receptor subtypes MC1R, MC3R, MC4R, and MC5R, with particular affinity for MC3R and MC4R at therapeutic doses
This treatment removes dead skin cells accumulated over the face
patients with these features should be strongly suspected of having MC4R -deficient obesity, and genetic evaluation should be considered
Additional information Related products IGF-LR3 1Mg Insulin Like Growth Factor (Research Use Only) IPAMORELIN 10mg Lypholized Powder (Research Use Only) View Certificate of Analysis (COA) DSIP 5mg (Research Use Only) SSMito-10mg Lypholized Powder (Research Use Only) View Certificate of Analysis (COA) TB-500 10MG (Research Use Only) SEMAX 10mg (Research Use Only) View Certificate of Analysis (COA)
Strategic funding should prioritize translational research that links fundamental discoveries in immunology and stem cell biology with clinical application, while also supporting the robust clinical trial infrastructure necessary to test these advanced therapies